DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20183920

Evaluation of learning and memory effect of atorvastatin and simvastatin in alprazolam induced amnesia in mice

Shashikala G., Jyothi C. H., Shashikala G. H.

Abstract


Background: The study was undertaken to evaluate the learning and memory effect of lipid lowering drugs atorvastatin and simvastatin in alprazolam induced amnesic mice.

Methods: The study was carried out on albino mice, divided into 4 groups of 6 animals each (either sex, 3-4 months of age, weight 25-30g). Amnesia was induced by administering Alprazolam (2mg/kg for 14 days) in all 4 groups from 1st to 14th day. In addition, group 2, 3 and 4 received Piracetam (400mg/kg), Atorvastatin (5mg/kg) and Simvastatin (5mg/kg) from 8th to 14th day respectively. The learning and memory of the animals was assessed by employing Elevated plus maze (EPM) and Step-down type passive avoidance (SDA) model.

Results: Results were compared among the different groups using one way-ANOVA followed by post hoc Tukey’s test. The measured parameters were compared with standard drug Piracetam. In EPM model Atorvastatin (p<0.049) and Simvastatin (p<0.007) were comparable with standard drug Piracetam, whereas in SDA model only simvastatin group (p<0.001) showed significant result.

Conclusions: In EPM model, both the statins showed significant improvement in learning and memory in alprazolam induced amnesic mice. However further studies are required to support these observations.


Keywords


Atorvastatin, Alprazolam, Alzheimer’s disease, Piracetam, Simvastatin

Full Text:

PDF

References


Alzheimer’s disease and other dementias. Kasper, Fauci, Hauser, Lango, Jameson. Harrison’s principles of Internal medicine, 19th Edition, volume 2, New Delhi, McGraw-Hill Education; 2015:2598-2608.

Joshi M, Gaonkar K, Mangoankar S, Satarkar S. Pharmacological investigation of Areca catechu for evaluation of learning, memory and behaviour in rats. Int Curr Pharm J. 2012;1(6):128-32.

Hersi M, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D. Risk factors associated with the onset and progression of Alzheimer’s disease: A systematic review of the evidence. J Neurotoxicol. 2017;61:143-87.

Liao JK, Laufs U. Pleiotropic effects of statins. Annu. Rev. Annu Rev Pharmacol Toxicol. 2005 Feb 10;45:89-118.

Mishra MR, Javed SM, Ahmad S, Mohan L. Effects of atorvastatin and simvastatin on learning and memory in aged Swiss albino mice. Int J Pharm Sci Rev Res. Nov-Dec 2013;23(2)n 61:383-37.

Parle M, Singh N. Reversal of memory deficits by atorvastatin and simvastatin in rats. Yakugaku Zasshi. 2007;127(7):1125-37.

Stuart SA, Robertson JD, Marrion NV, Robinson ESJ. Chronic Pravastatin but not Atorvastatin impairs cognitive function in two rodent models of learning and memory. 2013;8(9);e75467. PLOS ONE. www.plosone.org.

Zhou B, Teramukai S, Fukushima M. Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis. Dementia and Geriatric Cognitive Disorders. 2007;23(3):194-201. [PubMed: 17259710]

Orsi A, Sherman O, Woldeselassie Z. Simvastatin-associated memory loss. Pharmacotherapy. 2001;21(6):767-9.

Zamrini E, McGwin G, Roseman JM. Association between statin use and Alzheimer’s disease. Neuroepidemiology. 2004;23(1-2):94-8.

Kulkarni SK. New drug discovery process, Hand Book of Experimental Pharmacology, 3rd Edition, Delhi: Vallabh Prakashan; 2011:19-84.

Vogel HG. Psychotropic and Neurotropic Activity; Drug discovery and evaluation: pharmacological assays, 3rd Edition, Germany; 2007:565-661.

Chatterjee S, Krishnamoorthy P, Ranjan P, Roy A, Chakraborty A, Sabharwal MS, et al. Statins and cognitive function: an updated review. Curr cardiol Rep. 2015 Feb 1;17(2):4.